S1153 An Induction Dose of 12 Mg/D Budesonide Improves Clinical Efficacy in Comparison to a Standard Continuous Dose of 9 mg/d Active Pediatric Crohn's Disease

Authors :: Baruch Yerushalmi
Roland Greinwald
Gabriel Dinari
Arie Levine
Ron Shaoul
Efrat Broide
Pröls Markus
Michal Kori
Source :: Gastroenterology. 134:A-189
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Budesonide
medicine.medical_specialty
Hepatology
Pediatric Crohn's disease
business.industry
Gastroenterology
Pharmacology
Internal medicine
Medicine
Clinical efficacy
business
medicine.drug
Induction dose

Full Text Access

Tools